Literature DB >> 11850235

A comparative approach to structure-function studies of mammalian aromatases.

A Conley1, S Mapes, C J Corbin, D Greger, K Walters, J Trant, S Graham.   

Abstract

To date, structure--function studies of aromatase cytochrome P450 (P450arom) have been advanced by point mutation analyses utilizing almost exclusively the human enzyme, in conjunction with computer-generated models of the three-dimensional form of the enzyme based on prokaryotic cytochromes P450. Recent studies have identified duplicated isozymes of porcine P450arom, the gonadal and placental forms of which appear to differ substantially in substrate utilization and inhibitor sensitivity. We present a comparative approach to define regions of P450arom responsible for specific functional characteristics using complimentary DNAs encoding the porcine isozymes. Constructs encoding the native and chimeric porcine and human P450arom enzymes were transiently expressed and activity was assessed using the tritiated water assay. Sensitivity to inhibition by the imidazole etomidate was investigated, and P450arom expression was assessed by immunoblot analysis. All constructs yielded active P450arom, suggesting that exchanging entire structural elements does not preclude catalytic function. The activity of the gonadal isozyme was shown to be inhibited by etomidate at concentrations 185 and 300-fold lower than those required to induce a similar inhibition of the placental and human enzymes, respectively. In contrast, there was only a two-fold difference in the sensitivity of the gonadal and placental isozymes to inhibition by CGS16949A. Analysis of chimeric constructs indicated that the sensitivity to etomidate was associated with residues in the B, B' and C helices of the gonadal P450arom encompassing only one of six putative substrate recognition sites. Additionally, sensitivity to etomidate was not correlated with enzyme activity among the chimeric enzymes. Therefore, it appears that residues of the porcine gonadal P450arom that are responsible for etomidate binding may be distinct from those involved in substrate recognition and metabolism. These data support the notion that a comparative approach employing the use of chimeric enzymes provides a useful tool in directing point mutational analysis to determine residues important in inhibitor and perhaps substrate recognition of P450 enzymes such as P450arom. These studies are currently in progress.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11850235     DOI: 10.1016/s0960-0760(01)00145-5

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  5 in total

1.  Epigenetic alterations of CYP19A1 gene in Cumulus cells and its relevance to infertility in endometriosis.

Authors:  Elham Hosseini; Fereshteh Mehraein; Maryam Shahhoseini; Leili Karimian; Fatemeh Nikmard; Mahnaz Ashrafi; Parvaneh Afsharian; Reza Aflatoonian
Journal:  J Assist Reprod Genet       Date:  2016-05-11       Impact factor: 3.412

Review 2.  Estrogens in Male Physiology.

Authors:  Paul S Cooke; Manjunatha K Nanjappa; CheMyong Ko; Gail S Prins; Rex A Hess
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

3.  CYP19A1 Promoters Activity in Human Granulosa Cells: A Comparison between PCOS and Normal Subjects.

Authors:  Zohreh Hashemain; Amir Amiri-Yekta; Mona Khosravifar; Faezeh Alvandian; Maryam Shahhosseini; Saman Hosseinkhani; Parvaneh Afsharian
Journal:  Cell J       Date:  2022-04-27       Impact factor: 3.128

Review 4.  Challenges in the chemotherapy of Chagas disease: Looking for possibilities related to the differences and similarities between the parasite and host.

Authors:  Vitor Sueth-Santiago; Debora Decote-Ricardo; Alexandre Morrot; Celio Geraldo Freire-de-Lima; Marco Edilson Freire Lima
Journal:  World J Biol Chem       Date:  2017-02-26

5.  The planetary biology of cytochrome P450 aromatases.

Authors:  Eric A Gaucher; Logan G Graddy; Tang Li; Rosalia C M Simmen; Frank A Simmen; David R Schreiber; David A Liberles; Christine M Janis; Steven A Benner
Journal:  BMC Biol       Date:  2004-08-17       Impact factor: 7.431

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.